Serial #79359910
LIVE

Serial Number

79359910

Owner

Rejuveron Life Sciences AG

Attorney

John Alumit

Filing Date

Sep 12, 2022

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79359910 Trademark

Serial Number: 79359910 • Registration: 7876907

Serial #79359910 is a trademark filed by Rejuveron Life Sciences AG on September 12, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 36 (Insurance & Financial), Class 40 (Treatment & Processing), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Rejuveron Life Sciences AG (3 trademarks)

Wagistrasse 18

Entity Type: 99

Trademark Details

Filing Date

September 12, 2022

Registration Date

August 5, 2025

Published for Opposition

June 17, 2025

Goods & Services

Business data and management analysis, research and information services; retail and wholesale store services featuring medical products and dietary supplements; Providing consumer information in the field of longevity; organization of trade fairs for commercial purposes and providing related information to consumers; business assistance, management and administrative services; advertising, marketing and promotional services; retail and wholesale store services, and online retail and wholesale store services, in the fields of medicines, medical technology apparatus and devices, veterinary preparations, apparatus and devices, chemicals, foodstuffs, sanitary articles, agricultural products, and animal food

Preparation and dispensing of medications; providing information relating to the preparation and dispensing of medications; providing human hygienic and beauty care services; animal healthcare services; human healthcare services; agriculture services, namely, planting, growing, fertilizing, pruning and picking of agricultural plants for others; aquaculture services, namely, the cultivation and breeding of plants or animals in a water environment; horticulture and forestry services in the nature of gardening and landscaping services for others; dentistry; pharmaceutical consultancy services; medical services; advisory services relating to health

Prosthetic limbs, namely, arms, feet, legs, and artificial hip implants; orthopaedic and mobility aids, namely orthopaedic walkers, walkers to aid in mobility; medical and veterinary surgical apparatus and instruments; physical therapy equipment in the nature of foam rollers, manually-operated resistance tubing, weighted balls; medical equipment for physical exercises, namely, heart monitors to be worn during exercise

Food supplements and dietetic preparations adapted for medical purposes; hygienic preparations and articles, namely, disinfectants for hygienic purposes and disinfectants for medical purposes; dental preparations being for preventing and/or disclosing plaque and medicated dentifrices; pharmaceuticals and natural remedies for treating heart diseases, cancer, chronic lung diseases, neuronal conditions, gastrointestinal conditions; pharmaceutical preparations for treating migraine headaches, chronical diseases, traumatic and non-traumatic body injuries

Custom manufacture of pharmaceuticals by pharmaceutical compounders for others to order; custom manufacture of pharmaceuticals to order and according to the requirements of a customer; custom manufacture of dental prosthesis and dentures to order and according to the requirements of a customer; processing of raw materials for further manufacture of the production of food and beverages

Education services, namely, providing classes, seminars, workshops, and online tutorials in the field of life sciences and pharmaceuticals; providing of training in the field of life science and pharmaceuticals; planning and conducting of teaching, seminars and workshops in the fields of health, pharmacy, biotechnology, food science, food technology, agriculture and veterinary medicine

Scientific and technological services, namely, scientific research, analysis, testing, and clinical studies in the field of pharmaceuticals, life sciences; testing, authentication and quality control in the field of pharmaceuticals, and life sciences; medical and pharmacological research services; medical laboratory services; computer programming in the medical field; scientific investigations for medical purposes; design and development of medical diagnostic apparatus; provision of information and data relating to medical and veterinary research and development; research and development in the fields of pharmacy, biotechnology, food science, food technology, agriculture and veterinary medicine; information relating to medical and scientific research in the fields of pharmacy, biotechnology, food science, food technology, agriculture and veterinary medicine; providing temporary use of online non-downloadable computer software for accessing, managing, updating and displaying electronic databases, in particular, in the fields of health, pharmacy, biotechnology, food science, food technology, agriculture and veterinary medicine; development of pharmaceutical preparations and medicines; research and development of vaccines and medicines; consultancy in the field of pharmaceutical research; providing information about the results of clinical trials for pharmaceutical products; pharmaceutical product evaluation; biological research, clinical research, all being medical research in the field of radiology, chemotherapy, coronary artery bypass surgery, cell and cancer research; biomedical research services; testing of pharmaceuticals; clinical research in the field of radiology, chemotherapy, coronary artery bypass surgery, and stem cell therapy; medical research; inspection of pharmaceuticals; consultancy relating to biotechnology research; biology research consultancy; biochemistry research consultancy; chemical research and analysis services; preparation of technical reports featuring information related to research and development in the biotechnology field; genetic engineering services

Financial and monetary services, namely, financial consultancy, financial analysis, and monetary exchange; banking; financial and real estate valuation services; charitable, business, political fundraising and financial sponsoring of entertaining, sporting, and cultural events; real estate brokerage, agency, and investments services; insurance underwriting in the field of life, health, accident, and fire; pawn brokerage

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 5, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 12, 2026 FICS
FINAL DISPOSITION PROCESSED
Feb 12, 2026 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 5, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 5, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 5, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 17, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jun 17, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 11, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 14, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 12, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 12, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
May 12, 2025 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 10, 2025 GNFN
FINAL REFUSAL E-MAILED
Feb 10, 2025 GNFR
FINAL REFUSAL WRITTEN
Feb 10, 2025 CNFR
ASSIGNED TO EXAMINER
Jan 13, 2025 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 21, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 20, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 20, 2024 TROA
REFUSAL PROCESSED BY IB
Jul 20, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 1, 2024 RFCS
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 30, 2024 OPNX
REFUSAL PROCESSED BY MPU
Jun 27, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 27, 2024 RFCR
NON-FINAL ACTION WRITTEN
Jun 26, 2024 CNRT
ASSIGNED TO EXAMINER
Jun 26, 2024 DOCK
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Jun 26, 2024 RFWR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 7, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 7, 2024 OPNR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 28, 2023 RFCR
NON-FINAL ACTION WRITTEN
Jun 27, 2023 CNRT
ASSIGNED TO EXAMINER
Jun 25, 2023 DOCK
NEW REPRESENTATIVE AT IB RECEIVED
Mar 18, 2023 NREP
APPLICATION FILING RECEIPT MAILED
Jan 13, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 9, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 6, 2023 REPR